TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8848773

Group type: EXPERIMENTAL
Intervention: DEXA
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: BIA
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: V urea
Number of subjects: 18

Group type: COMPARATOR
Intervention: Gravimetric weight
Number of subjects: 18
Study: 2072836

Group type: EXPERIMENTAL
Intervention: 45-min walk at 60% VO2max
Number of subjects: 12

Group type: COMPARATOR
Intervention: rest in a seated position
Number of subjects: 12
Study: 6356177

Group type: EXPERIMENTAL
Intervention: 5 mg haloperidol tablets (average 4.0 tablets, 20.0 mg/day)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: 15 mg haloperidol tablets (average 3.9 tablets, 58.0 mg/day)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Higher oral haloperidol doses
Number of subjects: 41
Study: 31676259

Group type: EXPERIMENTAL
Intervention: HYPO (hypohydrated)
Number of subjects: 16

Group type: COMPARATOR
Intervention: EUHY (euhydrated)
Number of subjects: 16
Study: 28183347

Group type: EXPERIMENTAL
Intervention: Prehospital administration of thawed plasma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation of ICS principles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfamiliarity of clinicians with ICS culture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conflicting resource allocation priorities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Communication bottlenecks
Number of subjects: 0
Study: 27098548

Group type: EXPERIMENTAL
Intervention: Continuous interscalene blockade
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Continuous supraclavicular blockade
Number of subjects: 120

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 120
Study: 24428334

Group type: EXPERIMENTAL
Intervention: Alcohol-dependent patients (AP)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control patients (CP)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Alcohol-related interpretation bias
Number of subjects: 125
Study: 22024668

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg/day (force-titrated to 10 mg/day after 1 week) in the morning
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Nebivolol 5 mg/day (force-titrated to 10 mg/day after 1 week) in the evening
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo in the morning
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo in the evening
Number of subjects: 42
Study: 19503772

Group type: EXPERIMENTAL
Intervention: Thermal laser treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravitreal injections of steroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pharmaceuticals containing antibodies against vascular endothelial growth factor (VEGF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 0
Study: 17244293

Group type: EXPERIMENTAL
Intervention: Cash and Counseling (treatment group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medicaid services as usual (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cash and Counseling (treatment group) among elderly in Florida
Number of subjects: 0
Study: 15717934

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Vestibular Rehabilitation (VR)
Number of subjects: 36
Study: 11928802

Group type: EXPERIMENTAL
Intervention: Breast conservation therapy as a primary therapeutic procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiation therapy
Number of subjects: 0
Study: 10515471

Group type: EXPERIMENTAL
Intervention: Nimodipine treatment
Number of subjects: 127

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 127
Study: 7726705

Group type: EXPERIMENTAL
Intervention: Zidovudine
Number of subjects: 617

Group type: COMPARATOR
Intervention: Didanosine (500 mg/d)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Didanosine (750 mg/d)
Number of subjects: 617

Group type: COMPARATOR
Intervention: Zidovudine, Didanosine (500 mg/d), Didanosine (750 mg/d)
Number of subjects: 617
Study: 2304988

Group type: EXPERIMENTAL
Intervention: Silicone-gel implants
Number of subjects: 65

Group type: COMPARATOR
Intervention: Saline-filled implants
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Overall satisfaction
Number of subjects: 65
Study: 6798924

Group type: EXPERIMENTAL
Intervention: Rosoxacin 100 mg
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Rosoxacin 200 mg, 300 mg, or 400 mg
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Rosoxacin
Number of subjects: 126
Study: 29284097

Group type: EXPERIMENTAL
Intervention: 35% Lase Peroxide Sensy (LPS) + HL
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 35% hydrogen peroxide (HP) + HL
Number of subjects: 20

Group type: COMPARATOR
Intervention: 35% LPS
Number of subjects: 20

Group type: COMPARATOR
Intervention: 35% HP
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 25% LPS + HL
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 25% HP + HL
Number of subjects: 20

Group type: COMPARATOR
Intervention: 35% Whiteness HP (WHP)
Number of subjects: 20
Study: 27424687

Group type: EXPERIMENTAL
Intervention: KAA (α-keto analogs of essential amino acids)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Rhubarb
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control (Conservative management + placebo)
Number of subjects: 96
Study: 25004196

Group type: EXPERIMENTAL
Intervention: Yoga (1-hour class weekly for 10 weeks)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (supportive women's health education, 1-hour class weekly for 10 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control
Number of subjects: 64
Study: 21733292

Group type: EXPERIMENTAL
Intervention: Drug cues in abstaining smokers
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Cigarette cues in abstaining smokers
Number of subjects: 72

Group type: COMPARATOR
Intervention: Neutral cues in abstaining smokers
Number of subjects: 72
Study: 20691131

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus PRSF-L477 (1 × 10¹¹ cfu daily for 3 weeks)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus PRSF-L477
Number of subjects: 34
Study: 19033001

Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 672

Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 672
Study: 15717257

Group type: EXPERIMENTAL
Intervention: Didanosine
Number of subjects: 168

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study: 12832316

Group type: EXPERIMENTAL
Intervention: Nateglinide (120 mg)
Number of subjects: 1170

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1170
Study: 10944134

Group type: COMPARATOR
Intervention: Standard-dose neuraxis irradiation (36 Gy in 20 fractions)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Reduced-dose neuraxis irradiation (23.4 Gy in 13 fractions)
Number of subjects: 126
Study: 8818064

Group type: EXPERIMENTAL
Intervention: CATCH Eat Smart intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 56
Study: 1408298

Group type: EXPERIMENTAL
Intervention: Facet joint injection
Number of subjects: 86

Group type: COMPARATOR
Intervention: Facet nerve block
Number of subjects: 86
Study: 3869441

Group type: EXPERIMENTAL
Intervention: Short-acting glucagon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Depot-glucagon
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 0
Study: 3730766

Group type: EXPERIMENTAL
Intervention: Hexabrix 320
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: iohexol 300
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: iohexol 240
Number of subjects: 45
Study: 28358751

Group type: EXPERIMENTAL
Intervention: Angled trocar insertion
Number of subjects: 30

Group type: COMPARATOR
Intervention: Straight trocar insertion
Number of subjects: 30
Study: 27500336

Group type: EXPERIMENTAL
Intervention: Antenatal corticosteroids
Number of subjects: 850
Study: 24935579

Group type: EXPERIMENTAL
Intervention: EANI combined with hydrochloride palonosetron
Number of subjects: 120

Group type: COMPARATOR
Intervention: Hydrochloride palonosetron alone
Number of subjects: 120
Study: 22489444

Group type: EXPERIMENTAL
Intervention: Standard of care plus study map
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard care group (verbal description with consent documents)
Number of subjects: 30
Study: 20535016

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine and Placebo
Number of subjects: 0
Study: 18783503

Group type: EXPERIMENTAL
Intervention: Gabapentin (900 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 16170642

Group type: EXPERIMENTAL
Intervention: Levothyroxine (T)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Iodine (I)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Levothyroxine + Iodine (TI)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 1000
Study: 12914812

Group type: EXPERIMENTAL
Intervention: Suppressing anxious thoughts
Number of subjects: 32
Study: 11192136

Group type: EXPERIMENTAL
Intervention: Zaleplon 10 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Zaleplon 20 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Zolpidem 10 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Zolpidem 20 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8669674

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 375

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 375
Study: 1372855

Group type: EXPERIMENTAL
Intervention: Interferon gamma-1b (IFN gamma-1b)
Number of subjects: 0
Study: 3874009

Group type: EXPERIMENTAL
Intervention: 325 mg tid aspirin (ASA) plus 75 mg tid dipyridamole (DP)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: 325 mg tid aspirin (ASA)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Platelet-inhibiting therapy (ASA + DP)
Number of subjects: 147
Study: 31900097

Group type: EXPERIMENTAL
Intervention: ADHD group
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 107
Study: 31390595

Group type: EXPERIMENTAL
Intervention: Basal fat oxidation
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Maximal fat oxidation during exercise (MFO)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Basal metabolic rate (BMR)
Number of subjects: 74
Study: 29543631

Group type: EXPERIMENTAL
Intervention: Intravenous amisulpride (5 mg)
Number of subjects: 1147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1147
Study: 26686527

Group type: EXPERIMENTAL
Intervention: Green tea polyphenol infused with milk (GTPM)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 25274174

Group type: EXPERIMENTAL
Intervention: Comprehensive sex education program with family involvement
Number of subjects: 2453

Group type: EXPERIMENTAL
Intervention: Family activities during the first year of the program
Number of subjects: 2453
Study: 23715188

Group type: EXPERIMENTAL
Intervention: Amisped® (5 mg montelukast chewable tablets)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Singulair® (5 mg montelukast chewable tablets)
Number of subjects: 18
Study: 20131276

Group type: EXPERIMENTAL
Intervention: Golimumab plus MTX
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus MTX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Golimumab monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Golimumab 4 mg/kg plus MTX
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Golimumab with or without MTX
Number of subjects: 0
Study: 17267204

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate plus etoposide and ifosfamide
Number of subjects: 234

Group type: COMPARATOR
Intervention: High-dose methotrexate plus doxorubicin
Number of subjects: 234
Study: 16217785

Group type: EXPERIMENTAL
Intervention: Saturation recovery SSFP technique
Number of subjects: 16
Study: 12377864

Group type: EXPERIMENTAL
Intervention: Topical 4% amethocaine gel applied for 30 min prior to the radial arterial puncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical 4% amethocaine gel
Number of subjects: 0
Study: 10768802

Group type: EXPERIMENTAL
Intervention: Community-based intervention to increase fruit and vegetable intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Use of informational materials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Work sites with medium average baseline intake
Number of subjects: 0
Study: 8646678

Group type: EXPERIMENTAL
Intervention: Excision margin of 2 cm
Number of subjects: 769

Group type: COMPARATOR
Intervention: Excision margin of 5 cm
Number of subjects: 769
Study: 1514483

Group type: EXPERIMENTAL
Intervention: Gradual and prolonged balloon inflation with a perfusion balloon catheter (inflated to 6 atm over 3 minutes, median inflation time of 15 minutes)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Gradual and prolonged balloon inflation with a perfusion balloon catheter
Number of subjects: 140
Study: 4067888

Group type: EXPERIMENTAL
Intervention: Speech therapy for 24 weeks starting at 10 weeks post-stroke
Number of subjects: 0
Study: 30714684

Group type: EXPERIMENTAL
Intervention: EMDR + Standard Care (SC)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Standard Care (SC)
Number of subjects: 29
Study: 28479412

Group type: EXPERIMENTAL
Intervention: Family-focused grief therapy (not specified dosage or duration)
Number of subjects: 620

Group type: COMPARATOR
Intervention: Low-communicating families
Number of subjects: 620

Group type: COMPARATOR
Intervention: Uninvolved families
Number of subjects: 620

Group type: COMPARATOR
Intervention: Conflictual families
Number of subjects: 620
Study: 25230595

Group type: EXPERIMENTAL
Intervention: Thoracic radiotherapy (30 Gy in ten fractions)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Control (no thoracic radiotherapy)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: Thoracic radiotherapy
Number of subjects: 498

Group type: COMPARATOR
Intervention: Control
Number of subjects: 498
Study: 22775799

Group type: EXPERIMENTAL
Intervention: Static magnetic field exposure (1.5 T, 3 T, 7 T)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Mock scanner (0 T)
Number of subjects: 41
Study: 21455041

Group type: EXPERIMENTAL
Intervention: Left lateral position
Number of subjects: 512

Group type: COMPARATOR
Intervention: Right lateral position
Number of subjects: 512

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 512
Study: 18426714

Group type: EXPERIMENTAL
Intervention: Aboral pouch reconstruction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duodenal passage preserving version
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Duodenal passage preserving reconstruction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Duodenal exclusion
Number of subjects: 0
Study: 16427320

Group type: EXPERIMENTAL
Intervention: Pitch memory training (1 hour/day for 5 days)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Comparison of SL and WL groups post-training
Number of subjects: 14
Study: 14520654

Group type: EXPERIMENTAL
Intervention: Substantial acute recovery (improvement of ≥75% on NIHSS)
Number of subjects: 1184

Group type: COMPARATOR
Intervention: No substantial acute recovery
Number of subjects: 1184
Study: 10636259

Group type: EXPERIMENTAL
Intervention: BG9719
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 9268255

Group type: EXPERIMENTAL
Intervention: Extensive physician education over a 12-month period including case consultations, didactics, academic detailing, and role-play.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multifaceted program of collaborative care during the training period.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 8328656

Group type: EXPERIMENTAL
Intervention: Astemizole (10 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 3472139

Group type: EXPERIMENTAL
Intervention: Oral scopolamine hydrobromide solution (ScHBr), 0.02 mg/kg total body weight, rinsed in the mouth for 5 minutes before swallowing
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral scopolamine hydrobromide solution (ScHBr) during clinical dental examination procedures
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo during clinical dental examination procedures
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral scopolamine hydrobromide solution (ScHBr)
Number of subjects: 10
Study: 28718320

Group type: EXPERIMENTAL
Intervention: Prednisolone 37.5 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 28672854

Group type: EXPERIMENTAL
Intervention: Road safety education materials, two lectures on road safety, and a series of health education activities delivered over one year.
Number of subjects: 1312

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided).
Number of subjects: 1312
Study: 25639989

Group type: EXPERIMENTAL
Intervention: Houvast intervention (strengths-based intervention)
Number of subjects: 46
Study: 24002499

Group type: EXPERIMENTAL
Intervention: Antiviral treatment (nucleotide/nucleoside analogs: Lamivudine, adefovir dipivoxil, or entecavir)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Antiviral treatment
Number of subjects: 780

Group type: COMPARATOR
Intervention: Control group (no antiviral treatment)
Number of subjects: 780
Study: 21917146

Group type: EXPERIMENTAL
Intervention: Early continuous lumbar CSF-drainage and standard neurointensive care
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard neurointensive care only
Number of subjects: 0
Study: 18487572

Group type: EXPERIMENTAL
Intervention: High pain interference scores (>= 17)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Low pain interference scores (< 17)
Number of subjects: 599
Study: 17045093

Group type: EXPERIMENTAL
Intervention: Thoracic spinal manipulation
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 28
Study: 12749443

Group type: EXPERIMENTAL
Intervention: CO2
Number of subjects: 74

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 74
Study: 11079638

Group type: EXPERIMENTAL
Intervention: Intervention group 1
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Intervention group 2
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 106
Study: 8956928

Group type: COMPARATOR
Intervention: Temporal lobectomy in patients with unilateral mesial temporal lobe epilepsy (UMTLE) secondary to CNS infection
Number of subjects: 56
Study: 8054726

Group type: EXPERIMENTAL
Intervention: Autotransfusion after CABG (n = 42)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group with standard chest drainage (n = 33)
Number of subjects: 75
Study: 2493799

Group type: EXPERIMENTAL
Intervention: Magill anaesthetic breathing system
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lack anaesthetic breathing system
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both systems at lower fresh gas flow rate
Number of subjects: 12

Group type: COMPARATOR
Intervention: Both systems at higher fresh gas flow rate
Number of subjects: 12
Study: 30983087

Group type: EXPERIMENTAL
Intervention: Prasugrel (20 mg loading/3.75 mg maintenance)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Clopidogrel (300 mg loading/75 mg maintenance)
Number of subjects: 78
Study: 30396227

Group type: EXPERIMENTAL
Intervention: RAM cannula
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hudson prongs
Number of subjects: 12
Study: 28854542

Group type: EXPERIMENTAL
Intervention: Postoperative delirium (POD) patients
Number of subjects: 184

Group type: COMPARATOR
Intervention: Non-POD patients
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: POD patients
Number of subjects: 184
Study: 25740805

Group type: COMPARATOR
Intervention: Topical 5% natamycin
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Topical 1% voriconazole
Number of subjects: 118
Study: 23627803

Group type: EXPERIMENTAL
Intervention: Diabetics with PGC
Number of subjects: 192

Group type: EXPERIMENTAL
Intervention: Diabetics
Number of subjects: 192
Study: 20497250

Group type: EXPERIMENTAL
Intervention: Enfuvirtide plus optimized background (OB) regimen
Number of subjects: 155

Group type: COMPARATOR
Intervention: Optimized background (OB) alone (control group)
Number of subjects: 155
Study: 19118992

Group type: EXPERIMENTAL
Intervention: AA+DHA (220mg each/day)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: DHA (220mg/day)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 17544196

Group type: EXPERIMENTAL
Intervention: Zinc oxide‐eugenol (ZOE)
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Apexit
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Sealapex
Number of subjects: 270
Study: 15262190

Group type: EXPERIMENTAL
Intervention: EPA-rich oil (9 g oil/day for 4 weeks)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: DHA-rich oil (9 g oil/day for 4 weeks)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (olive oil, 9 g oil/day for 4 weeks)
Number of subjects: 42
Study: 11289288

Group type: EXPERIMENTAL
Intervention: Topical 0.3 percent nifedipine and 1.5 percent lidocaine ointment every 12 hours for two weeks
Number of subjects: 98

Group type: COMPARATOR
Intervention: Topical 1.5 percent lidocaine ointment
Number of subjects: 98
Study: 9879778

Group type: EXPERIMENTAL
Intervention: Paclitaxel 210 mg/m2 as a 3 hour infusion every three weeks until toxicity or progression
Number of subjects: 123
Study: 7586773

Group type: EXPERIMENTAL
Intervention: tiaprofenic acid
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: indomethacin
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: naproxen
Number of subjects: 21